‘You-on-a-chip’ for precision medicine
- 12 February 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Precision Medicine and Drug Development
- Vol. 3 (2) , 137-146
Abstract
Introduction: This forward-thinking review will introduce microphysiological systems (MPS), also known as organs-on-chips or tissue chips and their potential utility in personalized medicine. The authors will explain how this technology could push precision medicine efforts forward, using scenarios of current and projected use of MPS in different disease and treatment scenarios. Areas covered: The research discussed will include highlights of the last half decade of MPS development, with background information on microphysiological systems including within the context of precision medicine. This review will cite examples on cancer, neurological disorders and rare disease scenarios where MPS could be integrated into the decision-making process for physicians and healthcare providers. Expert commentary: This review will discuss how microphysiological systems could be used in a variety of situations for medical diagnostics, understanding disease mechanisms, and development of therapeutic treatment plans. A useful place in precision medicine efforts exists for MPS to help eliminate some of the ‘guesswork’ in standard therapeutic recommendations, and to inform future treatment regimens for subgroups of individuals based on the systems biology and -omics-based readouts these platforms can produce.Keywords
Funding Information
- National Center for Advancing Translational Sciences
This publication has 97 references indexed in Scilit:
- Genomic responses in mouse models poorly mimic human inflammatory diseasesProceedings of the National Academy of Sciences, 2013
- Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiationIntegrative Biology, 2013
- SyM-BBB: a microfluidic blood brain barrier modelLab on a Chip, 2012
- Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chipLab on a Chip, 2011
- Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersNature Reviews Neuroscience, 2011
- Neuropathological Alterations in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Phase II failures: 2008–2010Nature Reviews Drug Discovery, 2011
- Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T‐cellsBritish Journal of Pharmacology, 2010
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998